Lixisenatide is effective and well tolerated in patients with type 2 diabetes mellitus and renal impairment

被引：0
|
作者：
Hanefeld, M. [1 ]
Ambos, A. [2 ]
Arteaga, J. [3 ]
Leiter, L. A. [4 ]
Marchesini, G. [5 ]
Nikonova, E. [6 ]
Shestakova, M. [7 ]
Stager, W. [8 ]
Tambascia, M. [9 ]
Gomez Huelgas, R. [10 ]
机构：
[1] GWT TUD GmbH, Study Ctr Prof Hanefeld, Dresden, Germany
[2] North Estonia Med Ctr, Tallinn, Estonia
[3] Univ Nacl Colombia, Sch Med, Bogota, Colombia
[4] Univ Toronto, St Michaels Hosp, Toronto, ON M5S 1A1, Canada
[5] Univ Bologna, I-40126 Bologna, Italy
[6] Sanofi, Diabet Div, Global Med Afairs, Bridgewater, MA USA
[7] Endocrinol Res Ctr, Moscow, Russia
[8] Sanofi, Diabet Div, Bridgewater, MA USA
[9] Univ Estadual Campinas, Campinas, SP, Brazil
[10] Univ Reg Hosp, Malaga, Spain
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
841
引用
收藏
页码：S341 / S342
页数：2
相关论文
共 50 条
  • [41] Nateglinide, alone or in combination with metformin, is effective and well tolerated in treatment-naive elderly patients with type 2 diabetes
    Schwarz, S. L.
    Gerich, J. E.
    Marcellari, A.
    Jean-Louis, L.
    Purkayastha, D.
    Baron, M. A.
    DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 652 - 660
  • [42] Lixisenatide for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1513): : 1 - 3
  • [43] Lixisenatide and type 2 diabetes
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (09): : 309 - 309
  • [44] Rosiglitazone (RSG) is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T2DM)
    Kreider, M
    Miller, E
    Patel, J
    DIABETES, 1999, 48 : A117 - A117
  • [45] Renal Impairment Increases Serum Cancer Antigen 125 Levels in Patients with Type 2 Diabetes Mellitus
    Peng, You-Fan
    Sun, Jin-Fang
    Li, Ling
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (03): : 361 - 363
  • [46] Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
    Inagaki, Nobuya
    Kondo, Kazuoki
    Yoshinari, Toru
    Ishii, Manabu
    Sakai, Masaki
    Kuki, Hideki
    Furihata, Kenichi
    CLINICAL DRUG INVESTIGATION, 2014, 34 (10) : 731 - 742
  • [47] Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment
    Nobuya Inagaki
    Kazuoki Kondo
    Toru Yoshinari
    Manabu Ishii
    Masaki Sakai
    Hideki Kuki
    Kenichi Furihata
    Clinical Drug Investigation, 2014, 34 : 731 - 742
  • [48] Linagliptin is Efficacious and Well Tolerated in Asian Patients With Inadequately Controlled Type 2 Diabetes
    Zeng, Zhengpei
    Choi, Dong Seop
    Mohan, Viswanathan
    Emser, Angela
    Siddiqui, Kamran
    Gong, Yan
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2012, 61 : A300 - A300
  • [49] NAFLD association with renal impairment in type 2 diabetes patients
    Rivera, Jesus
    Pons, Monica
    Planas, Alejandra
    Simo Canonge, Rafael
    Baneras, Jordi
    Ferreira, Ignacio
    Jose Soler, Maria
    Seron, Daniel
    Genesca, Joan
    Manuel Pericas, Juan
    JOURNAL OF HEPATOLOGY, 2022, 77 : S149 - S149
  • [50] Renal affection in hypertensive patients with type 2 diabetes mellitus
    Makolkin, V. I.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (01) : 74 - 77
12345